Velphoro

Active Ingredient(s): Sucroferric Oxyhydroxide
FDA Approved: * November 27, 2013
Pharm Company: * VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
Category: Hyperphosphatemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Velphoro Overview

Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate. Contents 1 Mechanism of action 2 Medical use 3 Adverse effects 4 Choice of agent 4.1 Types 5 References 6 External links 6.1 Common Phosphate Binders Mechanism of action These agents work by binding t...

Read more Velphoro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Phosphate_binders

Recent Velphoro Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Velphoro: (1 result)

Sorted by National Drug Code

• 49230-645 Velphoro 500 mg/1 Oral Tablet, Chewable by Fresenius Medical Care North America

Other drugs which contain Sucroferric Oxyhydroxide or a similar ingredient: (1 result)

• SUCROFERRIC OXYHYDROXIDE